Breaking News Instant updates and real-time market news.

ACRS

Aclaris Therapeutics

$27.00

0.17 (0.63%)

07:06
08/08/17
08/08
07:06
08/08/17
07:06

Aclaris Therapeutics acquires Confluence Life Sciences in cash, stock deal

Aclaris Therapeutics announced that it has acquired Confluence Life Sciences, a privately held biotechnology company focused on the discovery and development of kinase inhibitors to treat inflammatory and immunological disorders and cancer. At the closing, Aclaris paid approximately $10M in cash and issued approximately 350,000 shares of its common stock, with a value of approximately $10M on the closing date, to the former equityholders of Confluence.

  • 08

    Aug

ACRS Aclaris Therapeutics
$27.00

0.17 (0.63%)

11/16/16
JMPS
11/16/16
NO CHANGE
JMPS
Aclaris Therapeutics price target raised to $39 from $34 at JMP Securities
JMP Securities analyst Donald Ellis says that data for Aclaris' A-101 drug was "highly positive" and he thinks that the drug is "substantially derisked." The analyst thinks that there is an 80% chance of the drug being approved, and he keeps an Outperform rating on the shares.
11/29/16
LEER
11/29/16
INITIATION
Target $54
LEER
Outperform
Aclaris Therapeutics initiated with an Outperform at Leerink
Leerink analyst Seamus Fernandez started Aclaris Therapeutics with an Outperform rating and $54 price target, saying he assumes its A-101 is approved and successful for seborrheic keratosis, with a 50% probability of success for A-101 for common warts.
04/26/17
LEER
04/26/17
NO CHANGE
Target $54
LEER
Outperform
Aclaris patent could be worth $15 per share, says Leerink
Leerink analyst Seamus Fernandez believes the A-101 patent announced today by Aclaris Therapeutics could add $15 per share to the company's net present value. The newly allowed patent expires in 2035, 11 years later than the analyst currently assumes loss of exclusivity in seborrheic keratosis. Extending the patent life of A-101 could increase the NPV contribution to $31 per share from $16, Fernandez tells investors in a research note. He keeps an Outperform rating on Aclaris with a $54 price target.
06/16/17
CANT
06/16/17
INITIATION
Target $50
CANT
Overweight
Aclaris Therapeutics initiated with an Overweight at Cantor
Cantor Fitzgerald analyst Louise Chen started Aclaris Therapeutics with an Overweight rating and $50 price target.

TODAY'S FREE FLY STORIES

BJ

BJ's Wholesale

$27.47

-1 (-3.51%)

10:48
09/25/18
09/25
10:48
09/25/18
10:48
Conference/Events
BJ's Wholesale participates in a conference call with William Blair »

Group investor conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 28

    Oct

  • 27

    Sep

VIOT

Viomi Technology

$0.00

(0.00%)

10:47
09/25/18
09/25
10:47
09/25/18
10:47
Syndicate
Breaking Syndicate news story on Viomi Technology »

Viomi Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

PETQ

PetIQ

$39.45

-1.62 (-3.94%)

10:46
09/25/18
09/25
10:46
09/25/18
10:46
Conference/Events
PetIQ participates in a conference call with William Blair »

Group investor conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

CVX

Chevron

$123.58

0.92 (0.75%)

10:45
09/25/18
09/25
10:45
09/25/18
10:45
Options
Chevron call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

ALDR

Alder Biopharmaceuticals

$16.88

0.125 (0.75%)

10:45
09/25/18
09/25
10:45
09/25/18
10:45
Conference/Events
Alder Biopharmaceuticals has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

TNDM

TNDM

10:42
09/25/18
09/25
10:42
09/25/18
10:42
Recommendations
TNDM analyst commentary  »

Baird not surprised by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Nov

10:40
09/25/18
09/25
10:40
09/25/18
10:40
General news
FX Action: USD-CAD »

FX Action: USD-CAD popped…

TWTR

Twitter

$28.93

0.34 (1.19%)

10:39
09/25/18
09/25
10:39
09/25/18
10:39
Hot Stocks
Twitter releases new policy to ban dehumanizing speech »

In a blog post, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 07

    Nov

VIOT

Viomi Technology

$0.00

(0.00%)

10:35
09/25/18
09/25
10:35
09/25/18
10:35
Syndicate
Breaking Syndicate news story on Viomi Technology »

Viomi Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FCAU

Fiat Chrysler

$18.22

-0.09 (-0.49%)

10:35
09/25/18
09/25
10:35
09/25/18
10:35
Options
Fiat Chrysler put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
09/25/18
09/25
10:35
09/25/18
10:35
General news
The U.S. consumer confidence »

The U.S. consumer…

CBM

Cambrex

$65.05

1.95 (3.09%)

10:31
09/25/18
09/25
10:31
09/25/18
10:31
Hot Stocks
Cambrex to expand, invest at High Point, North Carolina site »

Cambrex Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

VNTR

Venator Materials

$9.41

(0.00%)

10:25
09/25/18
09/25
10:25
09/25/18
10:25
Downgrade
Venator Materials rating change  »

Venator Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
09/25/18
09/25
10:25
09/25/18
10:25
General news
U.S. Richmond Fed manufacturing index climbed 5 points to 29 in September »

U.S. Richmond Fed…

RHHBY

Roche

$0.00

(0.00%)

10:25
09/25/18
09/25
10:25
09/25/18
10:25
Conference/Events
Roche to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 03

    Oct

10:25
09/25/18
09/25
10:25
09/25/18
10:25
Conference/Events
UBS waste market/recycling analyst to hold an analyst/industry conference call »

Analyst Windham, along…

VIOT

Viomi Technology

$0.00

(0.00%)

10:21
09/25/18
09/25
10:21
09/25/18
10:21
Syndicate
Breaking Syndicate news story on Viomi Technology »

Viomi Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FB

Facebook

$161.68

-3.72 (-2.25%)

10:20
09/25/18
09/25
10:20
09/25/18
10:20
Options
Heavy trading in Facebook as shares see relative weakness »

Heavy trading in Facebook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 07

    Nov

10:20
09/25/18
09/25
10:20
09/25/18
10:20
General news
Treasury Action: yields remain below highs »

Treasury Action: yields…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
09/25/18
09/25
10:17
09/25/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$220.79

(0.00%)

10:16
09/25/18
09/25
10:16
09/25/18
10:16
Periodicals
Apple still dealing with iPhone XR production issues, DigiTimes reports »

Apple has reportedly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
09/25/18
09/25
10:16
09/25/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$17.59

0.27 (1.56%)

, BJ

BJ's Wholesale

$27.30

-1.17 (-4.11%)

10:15
09/25/18
09/25
10:15
09/25/18
10:15
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

WEN

Wendy's

$17.59

0.27 (1.56%)

BJ

BJ's Wholesale

$27.30

-1.17 (-4.11%)

CENT

Central Garden & Pet

$38.28

(0.00%)

INSW

International Seaways

$20.57

0.63 (3.16%)

WELL

Welltower

$64.25

0.275 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 02

    Oct

  • 28

    Oct

  • 27

    Sep

INTC

Intel

$45.97

-0.94 (-2.00%)

, ON

ON Semiconductor

$18.54

-0.565 (-2.96%)

10:15
09/25/18
09/25
10:15
09/25/18
10:15
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

INTC

Intel

$45.97

-0.94 (-2.00%)

ON

ON Semiconductor

$18.54

-0.565 (-2.96%)

ADI

Analog Devices

$91.23

-3.78 (-3.98%)

DLTR

Dollar Tree

$84.38

-1.25 (-1.46%)

CY

Cypress Semiconductor

$14.53

-0.99 (-6.38%)

VALE

Vale

$14.88

0.085 (0.57%)

SBOW

SilverBow Resources

$28.70

-0.14 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 10

    Oct

  • 22

    Oct

  • 08

    May

CLX

Clorox

$150.49

0.51 (0.34%)

, DG

Dollar General

$107.69

0.4 (0.37%)

10:15
09/25/18
09/25
10:15
09/25/18
10:15
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

CLX

Clorox

$150.49

0.51 (0.34%)

DG

Dollar General

$107.69

0.4 (0.37%)

SAIC

SAIC

$80.82

1.94 (2.46%)

HP

Helmerich & Payne

$69.22

1.61 (2.38%)

CNI

Canadian National

$87.82

1 (1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.